Of 4,000 endocervical specimens tested with the Chlamydiazyme enzyme-linked immunosorbent assay (Abbott Laboratories), 233 (5.8%) gave positive results (A492 above the cutoff), which were confirmed with a blocking reagent (Abbott). An additional 34 specimens (14.6%) with chlamydial antigen were detected and confirmed with the direct fluorescent-antibody test (Syva) from among those 66 Chlamydiazyme-negative specimens which had A492s that ranged from 0.030 to the cutoff and that could be blocked by .50%o with the blocking reagent.
The sensitivity of the Chlamydiazyme enzyme-linked immunosorbent assay (ELISA) (Abbott Laboratories, North Chicago, Ill.) for detection of Chlamydia trachomatis in endocervical specimens has frequently been reported to be significantly lower than that of cell culture (1, 8) . Reduced detection of the pathogen has been associated, in part, with poor technique in collection of specimens (2, 3, 5, 6) . While these poorly collected specimens may contain levels of antigen below the Chlamydiazyme threshold of detection, they may have a sufficient number of viable Chlamydia cells to permit reproduction of the organism to a detectable level in culture.
The manufacturer's instructions indicate that a Chlamydiazyme result should be considered positive only if the A492 reading is greater than or equal to the mean result of three negative controls plus 0.100 nm. Improved Chlamydiazyme sensitivity, however, has been previously reported to be a result of performing direct fluorescent-antibody (DFA) tests on duplicate specimens whenever the ELISA-to-cutoff ratio of any original specimen ranged from 0.3 to 1.0 (7). The Chlamydiazyme blocking reagent (Abbott Laboratories) has been shown, with DFA tests, to reliably confirm truepositive Chlamydiazyme results and to identify false-positive results when the ELISA result is above the manufacturer's recommended cutoff (4) . There are no published studies, however, that have indicated that the blocking assay is equally reliable when the ELISA result is below the Chlamydiazyme cutoff. The purpose of the current study was to evaluate the ability of the Chlamydiazyme blocking reagent either to confirm or to eliminate the possibility of chlamydial antigen whenever the A492 was below, but within about 70% of, the cutoff. The hypothesis was that a specimen whose Chlamydiazyme result fell within that low borderline range but whose repeated ELISA result was not blocked by 250% with the blocking reagent might be considered truly negative for C. trachomatis antigen without any DFA testing. If the hypothesis were correct, the selective use of the DFA procedure only on those specimens with borderline Chlamydiazyme results which could be blocked by .50% might provide a cost-effective means of significantly increasing the Rapid assays for detection of chlamydial antigen in endocervical specimens have usually been reported to be considerably less sensitive than cell culture (1, 8) . In the current study, 233 of the patients had blocking reagent-confirmed, Chlamydiazyme-positive results with A492s above the manufacturer's suggested cutoff. An additional 34 (14.6%) C. trachomatis-infected patients were detected by retesting only those 5% of the specimens which gave borderline Chlamydiazyme results, ranging from 0.030 up to the cutoff. The DFA procedure did not confirm the presence C. trachomatis in any of the specimens with borderline ELISA results when those results could not be blocked with the blocking reagent. In contrast, the presence of chlamydial antigen was confirmed by DFA testing in 51% of those borderline specimens whose ELISA activity could be blocked by 50% or more.
It appears to be both cost-effective and clinically valuable to repeat the Chlamydiazyme test (with and without blocking reagent) on the relatively small number of endocervical specimens with initial A492s between 0.030 and the cutoff. Results of those tests which show blocking activity of greater than or equal to 50% could then be confirmed with the DFA procedure. Most (67.3%) of the specimens with borderline Chlamydiazyme results had blocking activity of less than 50%. These specimens could be considered negative for C. trachomatis without further testing by DFA.
Statistical analysis of the results was performed by Sally Cavanaugh.
